1 / 11

Influence of Pharmaceutical Company Funding on Drug Trials

Explore the impact of pharmaceutical funding on the outcomes, protocols, and quality of drug trials through a comprehensive literature review. Understand the implications of industry financing for medical research.

andres
Download Presentation

Influence of Pharmaceutical Company Funding on Drug Trials

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  2. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  3. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  4. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  5. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  6. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  7. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  8. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  9. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  10. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  11. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

More Related